Hydrochlorothiazide
NDC 50228-111 · ScieGen Pharmaceuticals, Inc.
Packages
50228-111-10 — 1000 TABLET in 1 BOTTLE (50228-111-10)
50228-111-30 — 30 TABLET in 1 BOTTLE (50228-111-30)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
50090-7478 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 50090-7571 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 50090-7664 — Losartan Potassium and Hydrochlorothiazide, 50090-7751 — Lisinopril and Hydrochlorothiazide, 50090-7764 — hydrochlorothiazide, 50090-7765 — hydrochlorothiazide, 50090-7772 — Hydrochlorothiazide, 50090-7773 — Hydrochlorothiazide, 50090-7817 — HYDROCHLOROTHIAZIDE, 50090-7821 — Losartan Potassium and Hydrochlorothiazide, 50228-112 — Hydrochlorothiazide, 50228-146 — Hydrochlorothiazide, 50228-147 — valsartan and hydrochlorothiazide, 50228-148 — valsartan and hydrochlorothiazide, 50228-149 — valsartan and hydrochlorothiazide, 50228-150 — valsartan and hydrochlorothiazide, 50228-151 — valsartan and hydrochlorothiazide, 50228-342 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 50228-343 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 50228-344 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, +854 more
Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels